PMC:7696151 / 82205-82454
Annnotations
LitCovid-PubTator
| Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
|---|---|---|---|---|---|
| 2388 | 24-27 | Gene | denotes | CA4 | Gene:12351 |
| 2427 | 163-166 | Chemical | denotes | HCQ | MESH:D006886 |
| 2428 | 191-195 | Chemical | denotes | iron | MESH:D007501 |
| 2429 | 206-209 | Chemical | denotes | ROS | MESH:D017382 |
| 2454 | 150-155 | Disease | denotes | tumor | MESH:D009369 |
LitCovid-PD-HP
| Id | Subject | Object | Predicate | Lexical cue | hp_id |
|---|---|---|---|---|---|
| T194 | 150-155 | Phenotype | denotes | tumor | http://purl.obolibrary.org/obo/HP_0002664 |
LitCovid-sentences
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T525 | 0-249 | Sentence | denotes | Firstly, the release of CA4 exerted anti-angiogenic effects in the vascular site, then FeAlg/HCQ were released into small nanogels and entered in the tumor, where HCQ inhibited autophagy and iron generated ROS with a synergic antitumor effect [161]. |